Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Dauntless who wrote (3596)	4/25/1998 11:35:00 PM
From: Hank	Read Replies (1) \| Respond to of 7041

The fun has indeed already begun. Who's numbers shall we or the FDA now believe? Joe P.'s as quoted in the IBD article? Dr. Fergusen's as quoted in the street.com article? The abstract from the Journal of Urology? The SGP numbers which are yet to revealed at the AUA conference? Will the real efficacy numbers please stand up! By the way, I have never in my life heard of anyone submitting an abstract for an up coming conference that quotes specific data that is then later claimed to be different from what will actually be presented at the meeting. This is extremely sloppy science by any measure. The excuse given by Fergusen that Irwin was "in a hurry" to submit an abstract is pure BS. After all, they supposedly have had the data for almost 6 months or more now. Correct? What's "the hurry"?